NR2F1 agonist 1 is a nuclear receptor NR2F1 agonist that specifically activates the dormancy program in malignant cells; it upregulates NR2F1 and downstream target genes involved in dormancy regulation; induces neural crest-like growth suppression in head and neck squamous cell carcinoma (HNSCC) through NR2F1 activation; and inhibits tumor growth in mouse primary tumor models.